Sezary Syndrome — Trials

Sezary Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 9%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 51–56 of 56 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00177190	In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)	completed	—	8	University of PittsburghOTHER	1	May 28, 2014	clinicaltrials
NCT00748319	Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma(KIR)	completed	N/A	495	Assistance Publique - Hôpitaux de ParisOTHER	1	Aug 22, 2012